drugset / Trial / NCT00084214
STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is designed to assess the efficacy of a weekly treatment regimen of STA-4783 and paclitaxel in comparison to paclitaxel alone on tumor response in metastatic melanoma patients.
Timeline
- Start
- 2004-05
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elesclomol | Small molecule | — | — |
| Subject | Paclitaxel | Small molecule | — | — |